Incidence of HIV Dropped From 1999 to 2016 in Uganda

This article originally appeared here.
Share this content:
Incidence of HIV Dropped From 1999 to 2016 in Uganda
Incidence of HIV Dropped From 1999 to 2016 in Uganda

THURSDAY, Nov. 30, 2017 (HealthDay News) -- The incidence of HIV infection declined significantly in Uganda between 1999 and 2016, according to a study published in the Nov. 30 issue of the New England Journal of Medicine.

M. Kate Grabowski, Ph.D., from the Johns Hopkins School of Medicine in Baltimore, and colleagues examined the correlation between the incidence of HIV and the scale-up of antiretroviral therapy (ART) and medical male circumcision in Uganda. Data were obtained from 30 communities for 33,937 individuals aged 15 to 49 years.

The researchers found that ART was introduced in 2004, and coverage was 69 percent by 2016 (72 percent among women and 61 percent among men). Among all HIV-positive persons, HIV viral-load suppression increased from 42 percent in 2009 to 75 percent by 2016 (P < 0.001). From 1999 to 2016 there was an increase in male circumcision (from 15 to 59 percent; P < 0.001). During this time period there was an increase in the percentage of adolescents who reported never having initiated sex (from 30 to 55 percent; P < 0.001). The mean incidence of HIV infection decreased by 42 percent by 2016, relative to the period before 2006, from 1.17 to 0.66 cases per 100 person-years (adjusted incidence rate ratio, 0.58).

"The incidence of HIV infection declined significantly with the scale-up of a combination strategy for HIV prevention, which provides empirical evidence that interventions for HIV prevention can have a population-level effect," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »